Studies with chemically modified cholera toxin derivatives showed that all treatments that decreased the ability of toxin to bind to mouse thymus cells or to polystyrene-coupled G M1 ganglioside caused a concomitant reduction in the toxin's ability to increase adenosine 3': 5'-cyclic phosphate (cyclic AMP) in thymus cells and skin vascular permeability in rabbits. Dissociation of the H (heavy) and L (light) subunits abolished the biologic activity without inhibiting receptor binding, as did treatment with arginyl-specific reagents (which did not change the aggregation state of the toxin). When thymus cells were incubated with 125I-labelled toxin at 37 C, only about 1% of the total cell-bound radioactivity was recovered in the cytosol supernate. Similar values were found for cells incubated with toxin at 0 C, and with 125I-labelled choleragenoid at 37 C or 0 C. Thymus cells rapidly bound~5 X 10 4 cholera toxin molecules per cell at both 0 C and 37 C. Much less, however, of the radioactive toxin bound at 37 C than of that bound at 0 C was displaced by addition of unlabelled toxin or choleragenoid. Similar temperaturerelated irreversible binding was noted with 125I-labelled choleragenoid. The relative amounts of Hand L subunits in the irreversibly cell-bound and in the displaced 125I-labelled toxin were indistinguishable. Treatment of thymus cells at 37 C, but not at 0 C, with l-ethyl-3-(3-dimethylaminopropyl) carbodiimide caused a lO-fold reduction of adenylate cyclase stimulation by cholera toxin without inhibiting activation by epinephrine or prostaglandin E 1, or appreciably altering the basal, unstimulated enzyme activity. The carbodiimide inhibited the cyclic AMP response to cholera toxin when added shortly after the toxin had bound to the cells (early in the lag phase).
Studies with chemically modified cholera toxin derivatives showed that all treatments that decreased the ability of toxin to bind to mouse thymus cells or to polystyrene-coupled G M1 ganglioside caused a concomitant reduction in the toxin's ability to increase adenosine 3': 5'-cyclic phosphate (cyclic AMP) in thymus cells and skin vascular permeability in rabbits. Dissociation of the H (heavy) and L (light) subunits abolished the biologic activity without inhibiting receptor binding, as did treatment with arginyl-specific reagents (which did not change the aggregation state of the toxin). When thymus cells were incubated with 125I-labelled toxin at 37 C, only about 1% of the total cell-bound radioactivity was recovered in the cytosol supernate. Similar values were found for cells incubated with toxin at 0 C, and with 125I-labelled choleragenoid at 37 C or 0 C. Thymus cells rapidly bound~5 X 10 4 cholera toxin molecules per cell at both 0 C and 37 C. Much less, however, of the radioactive toxin bound at 37 C than of that bound at 0 C was displaced by addition of unlabelled toxin or choleragenoid. Similar temperaturerelated irreversible binding was noted with 125I-labelled choleragenoid. The relative amounts of Hand L subunits in the irreversibly cell-bound and in the displaced 125I-labelled toxin were indistinguishable. Treatment of thymus cells at 37 C, but not at 0 C, with l-ethyl-3-(3-dimethylaminopropyl) carbodiimide caused a lO-fold reduction of adenylate cyclase stimulation by cholera toxin without inhibiting activation by epinephrine or prostaglandin E 1, or appreciably altering the basal, unstimulated enzyme activity. The carbodiimide inhibited the cyclic AMP response to cholera toxin when added shortly after the toxin had bound to the cells (early in the lag phase).
Many cell systems respond with changed metabolic activities after exposure to Vibrio cholerae enterotoxin. These manifestations of the action of toxin, which differ for various cell types, all appear to be secondary to the ability of the toxin to increase adenylate cyclase activity in mammalian cells [1] [2] [3] . Studies with 1211I-Iabelled cholera toxin have demonstrated that the toxin binds rapidly to and has high affinity for cell membranes [4] [5] [6] [7] [8] , yet there is a characteristic delay before increased adenylate cyclase activity
We are grateful to Dr. R. A. Finkelstein for choleragenoid, Dr. C. Miller for cholera toxin, Dr. J. Pike for prostaglandin E 1 , and to Dr. L. Svennerholm for G M1 ganglioside. We thank Ms. C. Norrman and G. Wallerstrom for skillful technical assistance.
This work was supported by grants from the Swedish Medical Research Council (project no. 16X-3382) and from the World Health Organization.
Please address requests for reprints to Dr. Jan Holmgren, Institute of Medical Microbiology, University of Goteborg, S-413 46 Goteborg, Sweden.
S64
is noticeable in intact cells [1] [2] [3] 9] . The events that take place during the "lag period," when the toxin, after binding to membrane receptors, activates adenylate cyclase, are unknown.
Structural analyses of cholera toxin by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis showed that the toxin consists of two types of noncovalently linked subunits, heavy (H) and light (L); their molecular weights were estimated to be 28,000 and around 8,000 daltons, respectively [10, 11] . The H:L protein ratio was 1 :2, a fact which suggested that the toxin (mol wt, 84,000 daltons) consists of 1 H subunit and probably six or seven L subunits linked by noncovalent bonds. Splitting of the H component by reduction and alkylation suggested it to be a disulfide-bridged dimer [11] . Immunodiffusion tests showed that the Hand L subunits constitute immunologically distinct entities [12, 13] .
Gel filtration at acid pH permitted complete separation of the Hand L subunits. In contrast to fractions containing both subunits, fractions com-prising isolated subunits were virtually nontoxic. This fact, in conjunction with the finding that choleragenoid (natural toxoid) contained the same L subunits as did toxin but lacked the H subunit, indicated that the H subunit is essential for the biologic activity of cholera toxin, but that the assistance of L subunits is required for an effect on intact tissues or cells [11] . Studies on binding to cells and to the probable receptor substance, ganglioside GMt (galactosyl-N-acetylgalactosaminyl [sialosyl] lactosyl ceramide; GGnSLC) [8, [14] [15] [16] , demonstrated very similar, specific receptor-binding properties of cholera toxin and choleragenoid. Furthermore, these studies revealed that purified L subunit of toxin bound effectively to cells and to G. Vl1 , whereas the H subunit did not [5, [12] [13] [14] .
Simultaneous investigations by Cuatrecasas et al. [4, [16] [17] [18] and subsequent reports by van Heyningen [19] , Finkelstein et al. [20] , and others [21] have corroborated many of these findings. 1 The present communication describes our studies designed to advance understanding of the structure-activity relationships of cholera toxin and to elucidate the mechanism of activation of adenylate cyclase.
Materials and Metbods
Preparation of cells. Thymus cells from CBA mice were obtained as previously described [5] by squeezing of the organs through a stainless steel grid and suspension of the cells in ice-cold medium.
Radioiodination of proteins. Cholera toxin and choleragenoid were labelled with 125 1 by the chloramine-T method [13] . The different preparations of labelled toxin had 65%-80% of the 'radioactivity confined to the H subunit. The biologic activity of the preparations was very similar to that of unlabelled toxin.
Chemical modification of toxin. Amino acid residues of cholera toxin were chemically modified with group-specific reagents [22] . Toxin was 1 These authors used a different nomenclature for the subunits of cholera toxin. Cuatrecasas treated with trypsin, carboxypeptidase, or leucine aminopeptidase in the presence or absence of urea, and with SDS, 2-mercaptoethanol, or glycine buffer (pH 3.8) as reported earlier [5, 22] .
Chemical modification of cells. Thymocytes were treated with 1-ethyl-3-( 3-d.imethylaminopropyl) carbodiimide (EDC) and washed as recently described [23] .
Electrophoresis in polyacrylamide. Regular polyacrylamide gel electrophoresis and SDS-polyacrylamide gel electrophoresis tests of toxin and toxin derivatives were performed according to previous descriptions [11, 13, 22] .
Binding to polystyrene-coated G M 1 ganglioside. Binding to ganglioside G M 1 was measured with a Gm-sorbent radioassay in which unlabelled toxin or toxin derivatives competed with 1251-labelled toxin for binding to ganglioside GMt that was attached to the inside of polystyrene test tubes [13, 22] .
Binding to cells. Binding of cholera toxin, toxin derivatives, or choleragenoid to cells was tested with radio iodinated toxin or choleragenoid mixed with various concentrations of the unlabelled proteins [5] .
Skin toxicity assay. The rabbit intradermal test of Craig [24] was used for determination of the vascular permeability factor activity of cholera toxin and its derivatives.
Incubation of cells and determination of adenosine 3':5'-cyclic phosphate (cyclic AMP). Unless specifically stated otherwise, cells were incubated in tissue culture medium RPMI 1640 supplemented with 10% freshly thawed fetal calf serum (RPMI-FCS). The cell density was 10 7 / ml, the temperature was 37 C, and the incubation time was 50 min unless specified otherwise.
The cells were harvested by centrifugation, and cyclic AMP was extracted and assayed essentially as described by Bourne et al. [25] . The cyclic AMP values reported are those obtained after correction for losses during isolation and varied by <10% in duplicate determinations.
Assay of adenylate cyclase. Intact cells (l07/ml) were incubated with and without cholera toxin as described for the cyclic AMP assay. The cells were suspended in a buffer (Tris, 40 mM; MgCI 2, 3.3 mM; theophylline, 10 mM; cyclic AMP 0.5 mM; bovine serum albumin, 0.1 %; dithiothreitol, 0.5 mM; pH 7.5); the buffer had been made In all instances where the treatment decreased the binding ability of cholera toxin, a concomitant reduction in biologic activity was observed. Amino group-reactive substances (e.g., picrylsulfonic acid) were particularly effective in decreasing binding to the receptor. Certain treatments destroyed the biologic activity without inhibiting the binding to cells or to G~n-ganglioside in vitro. Glycine buffer (pH 3.8) or SDS, as well as 2-merceptoethanol, had this differential effect, which was probably caused by separation of the cholera toxin subunits, as noted on polyacrylamide gel electrophoresis. On the other hand, similar differential effects on toxicity and receptor-binding were also noticed with three reagents that did not seem to change the aggregation state of the toxin, as judged from regular and SDS polyacrylamide gel electrophoresis tests (figure 1). These substances all were specific for arginine. Such a selective effect on toxicity was also found by treatisotonic with sucrose (0.32 msr). The cells were washed by centrifugation. To the cell pellet was added 100 III of this buffer (without sucrose), and the cells were disrupted by freezing and thawing twice. To the broken cells were added (I) 10 III of PBS (Na2HP04, 0.05 M; NaCI, 0.14 M; pH 7.2) containing myokinase (0.4 mg/ ml), phosphoenolpyruvate (50 mxr) and phosphoenol pyruvate kinase (0.4 mg/rnl) ; and (2) 10 III of [2-3H] adenosine triphosphate (ATP; 1 msr: 6 Ci/rnmol). The mix was incubated at 37 C for 15 min with shaking. When stimulation by epinephrine was studied, 10 III of 6 mM epinephrine was added at the start of this incubation. As a background control for the assay, heat-denatured (l00 C, 5 min) broken cells were incubated under the same conditions. The incubation was stopped by addition of (l) 0.65 mI of a mixture of cyclic AMP (0.15 mxr) and ATP (0.2 mxr), and (2) 0.25 mI of 20% trichloroacetic acid. The [3H] cyclic AMP formed was isolated by ion exchange chromatography and BaS04 precipitation according to the method of Krishna et aI. [26] . All tests were made in triplicate, and the values were corrected for loss of PH] cyclic AMP during isolation.
All chemicals used were purchased from Sigma Chemical Co. (St. Louis, Mo.) except [2-3H] ATP, which was from the Radiochemical Centre, Amersham, England.
Results
Recognition of an "active site" by chemical modification of cholera toxin. By modification of cholera toxin with amino acid residue-specific reagents, we have prepared numerous derivatives of cholera toxin and have tried to quantify the effects on biologic activity and receptor-binding properties. This work has indicated the presence of a biologically active site on the toxin that is unrelated to the receptor-binding site (s).
Results obtained with two assays of receptorbinding, i.e., binding to mouse thymus cells or to GMI-coated plastic tubes, showed excellent concurrence (table I) . Good agreement was also found between results obtained with the two assays of biologic activity, i.e., increase of cyclic AMP in thymus cells and vascular permeability increase in rabbit skin ( ment of the toxin with carboxypeptidase or trypsin in the presence of 2 M urea; in the absence of urea no enzymatic effect on any property of toxin was noted.
Studies of possible cell entry or membrane incorporation by radioactive toxin or H subunit.
The possibility that entry of cholera toxin or sub-S67 unit H into the cytoplasm is needed to initiate activation of adenylate cyclase was studied with 125I-Iabelled cholera toxin.
Experiments were performed for estimation of the amount of radioactive toxin material in the cytosol in relation to the total amount of cellbound radioactivity after incubation conditions (37 C for 45 min) that result in stimulation of adenylate cyclase. The intent also was to allow comparison of the extent of "entry" with that after incubation at 0 C, at which temperature the membrane lipids are rigid, and with the "entry" of 125I-Iabelled choleragenoid under the same conditions of incubation. Table 2 shows the results of such experiments. Over the 125-fold range of toxin concentration, irrespective of incubation temperature, the cytosol-associated radioactivity accounted for only about 1% of the cell-bound toxin. The values are probably too high since they include radioactivity resulting from dissociated or damaged toxin molecules that were originally bound to the membrane. Thus, a second and third freezing and thawing of the washed membrane fraction released about 40% and 15 %, respectively, of the activity found in the supernate (cytosol) after the first freezing and thawing of the intact cells. The proportion of cytosol-associated radioactivity in relation to total cell-bound radioactivity was very similar for Cytosol radioactivity (% of cell-bound) NOT/::. Mouse thymus cells, 10 7 / ml in tissue culture medium RPMI 1640 supplemented with 10% fetal calf serum (RPMI-FCS), were incubated with the indicated concentrations of 125I-labelled cholera toxin or choleragenoid for 45 min at 0 C or 37 C. The cells were washed by four cycles of centrifugation (approximately 500 g for 1 min) and resuspended in RPMI-FCS. Aliquots were removed for estimation of cell-bound radioactivity. The remaining cells were broken by freezing and thawing, and the supernates, after centrifugation at 6,000 g for 30 min and at 30,000 g for 15 min, were collected to represent cytosol. The values presented are means of two experiments, each performed in duplicate.
* Adenosine 3':5'-cyclic phosphate (cyclic AMP) was determined for cells incubated with the toxin at 37 C.
t The values at both temperatures for choleragenoid were similar to those for cholera toxin.
ing of active toxin, since 125I-labelled choleragenoid showed similarly increased "irreversibility" with increasing temperature of incubation (figure 3) . Examination of the subunit composition of cell-bound radioactive toxin by SDS-polyacrylamide gel electrophoresis gave no indication of a selective membrane or of cytoplasmic incorporation of H subunit after binding to the cell. If the radioactive H subunit is released from the surface cell-bound L subunits and if the H subunit is incorporated into the cell to a sufficient extent, proportionally more labelIed H subunit would be expected in the "irreversibly" cell-bound radioactive toxin after displacement by unlabelled toxin than in the "total" cell-bound radiolabelled toxin. However, as shown in table 3, after incubation at o C or at 37 C, the relative percentages of radioactive material migrating like the Hand L subunits were similar when "total" and "irreversibly" cell-bound toxin were compared. The percentages were also similar to the proportion of subunits in the added labelled toxin.
These experiments have given very similar results when repeated with different preparations of 125I-labelIed toxin and harvest of cells by centrifugation instead of by membrane filtration.
Inhibition of toxin-induced adenylate cyclase activation by cell modification. The significant delay between binding of cholera toxin to cells and the occurrence of a measurable effect on adenylate cyclase suggested that intermediary processes are required to translate the initial binding event into a cyclase-activating signal. We tried to identify, by interfering with its function, the possible presence of a cellular component of importance for such an intermediary signal.
Our approach to this problem has been to determine whether, by chemical modification of target mouse thymus cells, activation of adenylate cyclase by toxin can be inhibited specifically without loss of cyclase response to hormone stimulation. Table 4 shows that the EDC had a differential effect on cellular cyclic AMP response to cholera toxin and to epinephrine and prostaglandin E 1 • In six different experiments, 88%-95% inhibition of the cyclic AMP response to cholera toxin was registered in cells treated with 1 mM EDC. In contrast, the cyclic AMP response to the hormones was slightly enhanced; with epi- (table 2) . When we studied binding to thymus cells of 125I-labelled cholera toxin mixed with different concentrations of unlabelled toxin, the binding curves were similar for incubation temperatures of 0-37 C and incubation periods of 5-90 min (figure 2). However, studies of dissociation of cell-bound radioactive toxin after addition of excess unlabelled toxin demonstrated that the unlabelled toxin displaced significantly less of the 125I-Iabelled toxin bound at 37 C than of the toxin bound at 0 C.
The increased "irreversibility" of the toxin-cell association at higher temperature was studied in greater detail since it could reflect events of importance in the biologic action of toxin. Unlabelled toxin and choleragenoid displaced the same amounts of radioactive toxin from the cells. The temperature-related stabilization of the toxincell interaction was seen as early as 5-10 min and did not change greatly over a 90-min period. The phenomenon was not restricted to the bind- a. nephrine 33%-71 % enhancement was found in three experiments. This finding, together with the unchanged basal levels of cellular cyclic AMP, indicates that adenylate cyclase was not inhibited by treatment with EDC. The cell modifications described were studied in complex medium (RPMI-FCS). When cells were treated with EDC in PBS the inhibitory action was not observed. Different components of RPMI-FCS were therefore tested for a possible synergism with EDC in inhibition of the cyclic AMP response to cholera toxin. We found that the presence of NaHC0 3 , in contrast to other medium components tested, might be related to the inhibitory action of EDC (table 5) .
The possibility that EDC and bicarbonate affected the cellular binding sites for cholera toxin was investigated. There was no difference between cells treated with EDC and untreated cells in terms of binding of 125I-Iabelled toxin in competition with different concentrations of unlabelled toxin. Furthermore, other experiments showed that the proportion of "irreversibly" cellbound 125I-Iabelled toxin was similar in EDCtreated and untreated cells.
When cells were treated with EDC at different Figure 4 , right shows that the inhibitor was completely effective when it was added 5 min after the toxin but was not active when added 25 or 45 min later. Thus, EDC inhibited the cellular cyclic AMP response to cholera toxin provided that it was applied early in the toxin's lag period.
These results were substantiated further when adenylate cyclase activity was measured directly, as cellular accumulation of cyclic AMP, rather than indirectly as in the previously described experiments. Again, pretreatment of mouse thymocytes with EDC in RPMI-FCS medium inhibited adenylate cyclase activation by cholera toxin without inhibiting enzyme stimulation by epinephrine. Studies of the dose response showed that, for the cells used, the concentration of EDC must be within a narrow range, around 1 mM. Table 3 . Subunit composition of cell-bound radioactive cholera toxin.
Relative radioactivity of subunits (%) Radiolabelled cholera toxin H L "Total" cell-bound at 0 C 78.3 21.7 "Irreversibly" cell-bound at 0 C 78.1 21.9 "Total" cell-bound at 37 C 78.8 21.2 "Irreversibly" cell-bound at 37 C 77. 5 22.5 NOTE. Aliquots with 10 7 thymocytes/ml in tissue culture medium RPM1 1640 supplemented with 10% fetal calf serum were incubated for 45 min with 0.2 ug /rnl of 125I-toxin at either 0 C or 37 C. Thereafter, 10 ug/rnl of unlabelled toxin, or phosphate-buffered saline (PBS) was added, and the samples were incubated at 23 C for IS min. The cells were then separated from the medium by filtration and washed thrice with PBS. The distribution of radioactivity in Hand L subunits of the "total" cell-bound and the "irreversibly" cell-bound radiolabelled toxin material was estimated by sodium dodecyl sulfate (SDS)-polyacrylamide electrophoresis after suspension of the washed cells in 3% SDS-8 M urea at 56 C. The values presented are means of two to four experiments.
temperatures the inhibitory effect on .the cyclic AMP response to cholera toxin was highly dependent on temperature. At 37 C the inhibition was almost complete, at 23 C it was slight, and at o C it was negligible (figure 4, left).
In mouse thymus cells the lag period between the very rapid binding and the accumulation of cyclic AMP was 15-20 min. We tried to relate the kinetics of the cellular effect of cholera toxin Table 4 . Specific inhibition of adenosine 3':5'-cyclic phosphate (cyclic AMP) response to cholera toxin by cell modification with l-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC).
Cell-modifier None EDC in PBSi' EDC in PBS with 10 mM NaHC0 8 Cyclic AMP* 280 250 26
CyclicAMP (prnol/ 10 7 cells) Discussion NOTE. Thymocytes (10 7 in I 011 of tissue culture medium RPMI 1640 supplemented with 10% fetal calf serum) were incubated at 37 C for 30 min with or without EDC (101M) and then washed. Thereafter, the cells were suspended in fresh medium and incubated at 37 C with cholera toxin (10-9 M, 50 min), epinephrine (10-fJ M, 25 min), prostaglandin E 1 (10-4 M, 15 min), or with no stimulant (50 min). Intracellular cyclic AMP was then determined. we concluded that, for further understanding of the mode of action of cholera toxin, it was essential to try to answer two critical questions brought to light by our studies. (l) Must the toxin, in whole or in part, penetrate the plasma membrane in order to activate the cell (in all likelihood its adenylate cyclase system) or is the activation triggered by the mere binding of the toxin to the cell surface? (2) What roles are played by the two types of subunit, Hand L, in the activation process?
Cholera toxin
.: Then the treated cells were washed twice, supplied with fresh medium, and incubated with 10-9 M cholera toxin at 37 C for 50 min before intracellular cAMP was determined. Right, samples with 10 7 thymocytes were incubated at 37 C for 50 min in 1 ml of RPMI-FCS containing 10-9 M cholera toxin. At various times during this incubation EDC was added to a concentration of 1 mw. Intracellular cAMP was determined after completion of the incubation.
As models for further investigation we postulated three different ways in which cell binding of cholera toxin, but not of choleragenoid (which lacks the H subunit of the toxin), might lead to activation of adenylate cyclase [12] . (1) The H subunit has a positioning role for the L subunits, whereby binding of toxin, but not of choleragenoid L subunits, to OM! receptors triggers the activation of cyclase. (2) After the initial binding of cholera toxin to the plasma membrane surface, the whole toxin or its H subunit is taken into the interior of the cell and causes activation. (3) Cell binding via the L subunit to G~11 receptors facilitates contact of the H subunit with another membrane structure (second receptor) that is necessary for cyclase activation.
An activating, positioning role of the H subunit for the L subunits had to be considered as long as an active center in the H subunit itself had not been demonstrated, even though the indistinguishable receptor-binding properties of active toxin and of choleragenoid made the hypothesis less likely [5, 12, 17] . The present studies with chemically modified cholera toxin derivatives clearly indicate an active center in the toxin that is unrelated to the binding site(s). Arginyl-modifying reagents destroyed the biologic activity without interfering with binding to the receptor. The apparently unaffected subunit aggregation state of the toxin after treatment with these reagents suggests that the loss in biologic activity was caused by a critical modification of the H subunit in situ [22J. Direct evidence for an active site in the H subunit was recently presented by van Heyningen and King [27J, who found activation of adenylate cyclase in pigeon erythrocytes by isolated H subunit.
The hypothesis that the H subunit of cholera toxin has an intracellular action was attractive initially [12J. In contrast to the first model, this hypothesis could easily encompass the characteristic lag in activation of adenylate cyclase, as well as the reported localization in the intestinal mucosa of this enzyme to the basal and lateral membranes but not to the luminal surface, to which the toxin binds [28J. The experiments with radioiodinated toxin that we have described in this communication suggest, however, that entry of toxin into the cytosol of thymus cells is minimal. Only about 1% of the cell-associated radioactivity was found in the cytosol supernate after lysis and centrifugation of cells incubated with toxin, and control experiments indicated that much of this activity was due to dissociation or damage of membrane-bound toxin. Furthermore, the measured radioactivity in cytosol was the same after incubation of cells at 37 C and at°C; at the latter temperature the membrane is rigid and has little permeability. Similar results were obtained in parallel experiments with radioactive choleragenoid. From these findings we must conclude that it was not possible to demonstrate significant, specific entry of radiolabelled toxin or H subunit into the cytosol of mouse thymus cells. Based on work with toad erythrocytes, Bennet and Cuatrecasas [9J have also reported negligible entry of radioactive toxin. Thus, there is little support for the validity of the "cell entry model," but this model is not excluded if one postulates an enzymatic action allowing activation of many adenylate cyclase molecules by single molecules of toxin [29J. Transfer of cytosol from toxin-treated cells to membranes of untreated cells and examination of adenylate cyclase stimulation may resolve. this problem.
The third model implies initial binding of L subunits to G M 1 receptors followed by interaction of an active site on the H subunit with a second membrane component. This model was proposed from early experiments [l1J that were later confirmed and extended with toxin fractions contain-ing different ratios of Land H subunits (I. Lonnroth and C. Lonnroth, unpublished observations). Only derivatives with certain subunit proportions were highly active, and the addition to active fractions or intact toxin of one or the other subunit resulted in decreased activity. Since isolated H subunit did not bind appreciably to the cell surface, it was suggested that the receptor-binding via L subunit is required to bring the H subunit into contact with its tentative membrane target or that the binding facilitates such contact [5] .
This model is difficult to test directly because of the methodological problems in isolating more or less hydrophobic membrane components with the biological properties retained. The results of the present study are all compatible with the third model and may be interpreted to give some indirect support to its validity, but they could also be integrated into other theories. Of great potential interest is the portion of cell-bound toxin that rapidly (within 5-10 min) became inaccessible to dissociation in the presence of excess concentrations of toxin. In agreement with observations by Cuatrecasas [30J who studied fat cells, we found with thymus cells that this stabilization of binding is temperature dependent. At 37 C the nondissociable portion comprises about half of the radioactivity of the cell-bound 125I-Iabelled toxin. Choleragenoid was as effective as toxin in displacing cell-bound radioactive toxin. Since choleragenoid can inhibit effectively the biologic action of toxin when added to cells before or simultaneously with the toxin but is unable to reverse the action when added shortly after the toxin [8, 17, 30J, it seems likely that the "irreversibly" cell-bound toxin is the portion responsible for activation. At first we thought that this nondissociable portion might represent a selective cell incorporation of H subunit. However, on further testing, radiolabelled choleragenoid showed similar temperature-related irreversible binding. Furthermore, the non dissociated cell-bound toxin had the same subunit composition as the dissociable fraction of toxin. These findings suggest that the L subunits are primarily responsible for the observed temperature-dependent tendency of toxin to associate irreversibly with the cell membrane and that the H subunit remains linked to the L subunits during this process. Conceivably, the H subunit could be brought into contact with a normally inaccessible membrane structure through this mechanism.
Bennett, O'Keefe, and Cuatrecasas [9, 32] have proposed mechanistic theories similar to our third model. They proposed that an initially inactive toxin-GMt ganglioside complex is formed, which, by a process involving lateral movement, is relocated to enable an activating bimolecular association between the H subunit and adenylate cyclase. Our experiments on cell modification with the carbodiimide EDC open new possibilities for characterization of the cell structure with which the H subunit interacts. This structure is apparently not involved in stimulation of cyclase by epinephrine or prostaglandin E 1 ; it is probably more or less unique to the toxin. Further studies of the effects exerted by EDC might help to discriminate between the various theories for the action of cholera toxin. In particular, it is important to try to distinguish between a modification of a membrane component regulating the activity of adenylate cyclase (model 3) and an effect by the carbodiimide on an entry site or cytosol component (model 2).
Many cell-types have been used in different laboratories for studies on the mode of action of cholera toxin. Findings in one kind of cell might not have general applicability and, obviously, models deduced from work with nonintestinal cells should ultimately be tested in the natural target tissue, the mucosa of the small intestine.
